Pyxis Oncology Inc. (PYXS)
NASDAQ: PYXS
· Real-Time Price · USD
2.06
0.00 (0.00%)
At close: Sep 26, 2025, 10:59 AM
0.00% (1D)
| Bid | 2.06 |
| Market Cap | 128.07M |
| Revenue (ttm) | 6.22M |
| Net Income (ttm) | -96.29M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -1.3 |
| Forward PE | -1.85 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.08 |
| Volume | 70,913 |
| Avg. Volume (20D) | 673,771 |
| Open | 2.05 |
| Previous Close | 2.06 |
| Day's Range | 2.05 - 2.11 |
| 52-Week Range | 0.83 - 5.39 |
| Beta | 1.15 |
| Ex-Dividend Date | n/a |
About PYXS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PYXS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PYXS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
-5.83%
Pyxis Oncology shares are trading higher after the...
Unlock content with
Pro Subscription
10 months ago
-45.03%
Pyxis Oncology shares are trading lower after William Blair downgraded the stock from Outperform to Market Perform.
